Literature DB >> 6252104

In vitro effects of histamine on eosinophil migration.

A A Wadee, R Anderson, R Sher.   

Abstract

Histamine at concentrations of 5 X 10(-6) to 5 X 10(-5) M increased eosinophil movement to endotoxin-activated serum (EAS). This effect was due entirely to stimulation of random migration (chemokinesis). Directional motility (true chemotaxis) was inhibited by these concentrations. Regulation of chemotaxis was apparently mediated via an H2 receptor as metiamide, an H2 receptor antagonist, but not diphenylhydramine hydrochloride, an H1 receptor antagonist, blocked the histamine-induced inhibition of chemotaxis. Both histamine and metiamide when used alone had no effect on eosinophil motility. The histamine effects on motility were associated with increased levels of intracellular cAMP, whereas cGMP levels were not affected.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252104     DOI: 10.1159/000232643

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  12 in total

Review 1.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.

Authors:  B J McEwen; B P Wilcock; P Eyre
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

3.  Histamine H(2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation.

Authors:  C I Ezeamuzie; E Philips
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

5.  Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor.

Authors:  Karen F Buckland; Timothy J Williams; Dolores M Conroy
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

6.  The enhancement of eosinophil function by lymphocyte supernatants.

Authors:  R Sher; A Wadee; M Joffe
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

7.  Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis.

Authors:  Chenyu Sun; Yue Chen; Lei Hu; Yile Wu; Mingming Liang; Mubashir Ayaz Ahmed; Chandur Bhan; Zhichun Guo; Hongru Yang; Yijing Zuo; Yue Yan; Qin Zhou
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

8.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

9.  COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.

Authors:  Robert W Malone; Philip Tisdall; Philip Fremont-Smith; Yongfeng Liu; Xi-Ping Huang; Kris M White; Lisa Miorin; Elena Moreno Del Olmo; Assaf Alon; Elise Delaforge; Christopher D Hennecker; Guanyu Wang; Joshua Pottel; Nora Smith; Julie M Hall; Gideon Shapiro; Anthony Mittermaier; Andrew C Kruse; Adolfo García-Sastre; Bryan L Roth; Jill Glasspool-Malone; Darrell O Ricke
Journal:  Res Sq       Date:  2020-06-22

10.  Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.

Authors:  Jeffrey F Mather; Richard L Seip; Raymond G McKay
Journal:  Am J Gastroenterol       Date:  2020-10       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.